| HOME >> BIOLOGY >> TECHNOLOGY |
FIGURE 29 U.S. MARKET FOR KINASE INHIBITORS USED AS ANTINEOPLASTIC AGENTS,
2009-2016 ($ MILLIONS) 98
FIGURE 30 U.S. MARKET FOR KINASE INHIBITORS USED AS IMMUNOSUPPRESSANTS,
2009-2016 ($ MILLIONS) 100
FIGURE 31 U.S. MARKET FOR KINASE INHIBITORS USED IN AGE-RELATED MACULAR
DEGENERATION, 2009-2016 ($ MILLIONS) 102
FIGURE 32 MARKET SHARE OF APPLICATIONS OF KINASE INHIBITORS IN U.S., 2010 (%) 103
FIGURE 33 NUMBER OF PATENTS BY YEAR, 2008 TO END OF FEBRUARY 2012 105
FIGURE 34 NUMBER OF PATENTS BY YEAR, 2008 TO END OF FEBRUARY 2012 (%) 106
FIGURE 35 PATENTS BY CATEGORY FOR KINASE INHIBITORS 2008 TO END OF FEBRUARY
2012 107
FIGURE 36 PATENTS BY TYPE FOR TYROSINE KINASE INHIBITORS 2008 TO END OF
FEBRUARY 2012 108
FIGURE 37 PATENTS BY TYPE FOR SERINE/THREONINE KINASE INHIBITORS, 2008 TO END
OF FEBRUARY 2012 108
FIGURE 38 NUMBER OF U.S. PATENTS BY COUNTRY FOR KINASE INHIBITORS, 2008 TO END
OF FEBRUARY 2012 110
FIGURE 39 PATENT SHARES BY COUNTRY FOR KINASE INHIBITORS, 2010–2012 (%) 111
FIGURE 40 PATENTS BY ASSIGNEE FOR KINASE INHIBITORS, 2008 THROUGH END OF
FEBRUARY 2012 112
To order this report:
Therapy Industry: Kinase Inhibitors: Global Markets -- Focus on the U.S.
Nicolas Bombourg
Reportlinker
Email: nicolasbombourg@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626
| SOURCE Reportlinker Copyright©2012 PR Newswire. All rights reserved |